Zinc (Zn) metal and its alloys have received a lot of
interest
in biomedical applications due to their biodegradability, biocompatibility,
antimicrobial activity, and ability to stimulate tissue regeneration.
Bulk Zn has been successfully utilized in a variety of implant applications,
most notably as bioabsorbable cardiac stents and orthopedic fixation
devices, where it provides adequate mechanical properties while also
releasing helpful Zn ions (Zn2+) during degradation. Such
beneficial ions are dose-dependent and, when released in excess, can
induce cellular toxicity. In this study, we hypothesize that embedding
Zn metal particles into a polymer nanofibrous scaffold will enable
control of the degradation and time release of the Zn2+. We designed and fabricated two polymer scaffolds, polycaprolactone
(PCL) and polycaprolactone-chitosan (PCL-CH). Each scaffold had an
increasing amount of Zn. Several physicochemical properties such as
fiber morphology, crystallinity, mechanical strength, hydrophilicity,
degradation and release of Zn2+, thermal properties, chemical
compositions, and so forth were characterized and compared with the
PCL fibrous scaffold. The biological properties of the scaffolds were
evaluated in vitro utilizing direct and indirect cytotoxicity assays
and cell viability. All the data show that the addition of Zn changed
various physical properties of the PCL and PCL-CH scaffolds except
their chemical structure. Further investigation reveals that the PCL-CH
scaffolds degrade the Zn particles relatively faster than the PCL
because the presence of the hydrophilic CH influences the faster release
of Zn2+ in cell culture conditions as compared to the PCL
fibrous scaffold. The combined advantages of CH and Zn in the PCL
scaffold enriched 3T3 fibroblast cells' survival and proliferation
except the ones with the higher concentration of Zn particles. These
new composite scaffolds are promising and can be further considered
for tissue healing and regeneration applications.